• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用SIFT和PolyPhen预测功能丧失和功能获得性突变。

Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.

作者信息

Flanagan Sarah E, Patch Ann-Marie, Ellard Sian

机构信息

Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter, Exeter, United Kingdom.

出版信息

Genet Test Mol Biomarkers. 2010 Aug;14(4):533-7. doi: 10.1089/gtmb.2010.0036.

DOI:10.1089/gtmb.2010.0036
PMID:20642364
Abstract

CONTEXT

The interpretation of novel missense variants is a challenge with increasing numbers of such variants being identified and a responsibility to report the findings in the context of all available scientific evidence. Various in silico bioinformatic tools have been developed that predict the likely pathogenicity of missense variants; however, their utility within the diagnostic setting requires further investigation.

AIM

The aim of our study was to test the predictive value of two of these tools, sorting intolerant from tolerant (SIFT) and polymorphism phenotyping (PolyPhen), in a set of 141 missense variants (131 pathogenic, 8 benign) identified in the ABCC8, GCK, and KCNJ11 genes.

METHODS

Sixty-six of the mutations caused a gain of protein function, while 67 were loss-of-function mutations. The evolutionary conservation at each residue was also investigated using multiple sequence alignments from the UCSC genome browser.

RESULTS

The sensitivity of SIFT and PolyPhen was reasonably high (69% and 68%, respectively), but their specificity was low (13% and 16%). Both programs were significantly better at predicting loss-of-function mutations than gain-of-function mutations (SIFT, p = 0.001; PolyPhen, p < or = 0.0001). The most reliable method for assessing the likely pathogenicity of a missense variant was to investigate the degree of conservation at the affected residue. Eighty-eight percent of the mutations affected highly conserved residues, while all of the benign variants occurred at residues that were polymorphic across multiple species.

CONCLUSIONS

Although SIFT and PolyPhen may be useful in prioritizing changes that are likely to cause a loss of protein function, their low specificity means that their predictions should be interpreted with caution and further evidence to support/refute pathogenicity should be sought before reporting novel missense changes.

摘要

背景

随着新发现的错义变异数量不断增加,对其进行解读成为一项挑战,并且有责任在所有现有科学证据的背景下报告研究结果。已经开发了各种计算机生物信息学工具来预测错义变异的可能致病性;然而,它们在诊断环境中的实用性需要进一步研究。

目的

我们研究的目的是在一组在ABCC8、GCK和KCNJ11基因中鉴定出的141个错义变异(131个致病性变异,8个良性变异)中测试其中两种工具,即从耐受中筛选不耐受(SIFT)和多态性表型分析(PolyPhen)的预测价值。

方法

其中66个突变导致蛋白质功能获得,而67个是功能丧失突变。还使用加州大学圣克鲁兹分校基因组浏览器的多序列比对研究了每个残基的进化保守性。

结果

SIFT和PolyPhen的敏感性相当高(分别为69%和68%),但它们的特异性较低(分别为13%和16%)。这两个程序在预测功能丧失突变方面比功能获得突变要好得多(SIFT,p = 0.001;PolyPhen,p≤0.0001)。评估错义变异可能致病性的最可靠方法是研究受影响残基的保守程度。88%的突变影响高度保守的残基,而所有良性变异都发生在多个物种中具有多态性的残基上。

结论

尽管SIFT和PolyPhen可能有助于对错义变异进行优先级排序,这些变异可能导致蛋白质功能丧失,但其低特异性意味着对其预测应谨慎解读,在报告新的错义变异之前应寻求更多支持/反驳致病性的证据。

相似文献

1
Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.使用SIFT和PolyPhen预测功能丧失和功能获得性突变。
Genet Test Mol Biomarkers. 2010 Aug;14(4):533-7. doi: 10.1089/gtmb.2010.0036.
2
Computational Analysis of Missense Variants of G Protein-Coupled Receptors Involved in the Neuroendocrine Regulation of Reproduction.参与生殖神经内分泌调节的G蛋白偶联受体错义变体的计算分析
Neuroendocrinology. 2016;103(3-4):230-9. doi: 10.1159/000435884. Epub 2015 Jun 18.
3
Comparison of Bioinformatics Prediction, Molecular Modeling, and Functional Analyses of FOXC1 Mutations in Patients with Axenfeld-Rieger Syndrome.Axenfeld-Rieger综合征患者中FOXC1突变的生物信息学预测、分子建模及功能分析比较
Hum Mutat. 2017 Feb;38(2):169-179. doi: 10.1002/humu.23141. Epub 2016 Nov 21.
4
In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing.BRCA1 和 BRCA2 错义变异的计算机分析及其在分子遗传学检测中的相关性。
Sci Rep. 2021 May 27;11(1):11114. doi: 10.1038/s41598-021-88586-w.
5
Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.评估五种计算机预测工具单独或联合使用时以及两种元服务器对长QT综合征基因突变进行分类的预测准确性。
BMC Med Genet. 2015 May 13;16:34. doi: 10.1186/s12881-015-0176-z.
6
CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein.CoDP:通过组合 MSH6 蛋白的不同性质来预测未分类遗传变异的影响。
J Biomed Sci. 2013 Apr 28;20(1):25. doi: 10.1186/1423-0127-20-25.
7
Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.婴儿期高胰岛素血症:新的ABCC8和KCNJ11突变以及其他位点异质性的证据。
J Clin Endocrinol Metab. 2004 Dec;89(12):6224-34. doi: 10.1210/jc.2004-1233.
8
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.用于临床诊断中罕见BRCA1/2错义变异分类的计算机预测工具的性能
BMC Med Genomics. 2018 Mar 27;11(1):35. doi: 10.1186/s12920-018-0353-y.
9
Performance of In Silico Tools for the Evaluation of UGT1A1 Missense Variants.用于评估UGT1A1错义变体的计算机工具的性能
Hum Mutat. 2015 Dec;36(12):1215-25. doi: 10.1002/humu.22903. Epub 2015 Oct 5.
10
A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation.一种新的 ABCC8 突变说明了与单个突变相关的糖尿病表型的可变性。
Diabetes Metab. 2012 Apr;38(2):179-82. doi: 10.1016/j.diabet.2011.12.001. Epub 2012 Feb 11.

引用本文的文献

1
GOLF: A Generative AI Framework for Pathogenicity Prediction of Myocilin OLF Variants.高尔夫:一种用于肌纤蛋白OLF变体致病性预测的生成式人工智能框架。
bioRxiv. 2025 Jun 24:2025.06.17.660210. doi: 10.1101/2025.06.17.660210.
2
An evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer.对洛拉替尼作为一种潜在疗法用于治疗与癌症相关的间变性淋巴瘤激酶(ALK)蛋白酪氨酸激酶结构域中新型氨基酸替代的评估。
Front Pharmacol. 2025 Jun 18;16:1605314. doi: 10.3389/fphar.2025.1605314. eCollection 2025.
3
GAIN-BRCA: a graph-based AI-net framework for breast cancer subtype classification using multiomics data.
GAIN-BRCA:一种基于图的人工智能网络框架,用于利用多组学数据进行乳腺癌亚型分类。
Bioinform Adv. 2025 May 14;5(1):vbaf116. doi: 10.1093/bioadv/vbaf116. eCollection 2025.
4
REVEL Is Better at Predicting Pathogenicity of Loss-of-Function than Gain-of-Function Variants.REVEL在预测功能丧失型变异的致病性方面比功能获得型变异更出色。
Hum Mutat. 2023 Dec 4;2023:8857940. doi: 10.1155/2023/8857940. eCollection 2023.
5
Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.新辅助顺铂化疗前后肌层浸润性膀胱癌中DNA损伤修复基因的改变
Eur Urol Open Sci. 2024 Dec 5;71:38-48. doi: 10.1016/j.euros.2024.10.022. eCollection 2025 Jan.
6
Next-generation sequencing uncovers crucial mutated genes and potential therapeutic targets in ovarian cancer patients.下一代测序揭示了卵巢癌患者中关键的突变基因和潜在的治疗靶点。
Am J Transl Res. 2024 Oct 15;16(10):5990-6007. doi: 10.62347/XNGV7396. eCollection 2024.
7
New ABL1 Kinase Domain Mutations in BCR::ABL1-Positive Acute Lymphoblastic Leukemia.BCR::ABL1 阳性急性淋巴细胞白血病中的新型 ABL1 激酶结构域突变。
Cancer Med. 2024 Oct;13(20):e70317. doi: 10.1002/cam4.70317.
8
Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning.个性化肿瘤学在嗜铬细胞瘤和副神经节瘤中的应用:整合遗传分析与机器学习。
Med Oncol. 2024 Oct 17;41(11):290. doi: 10.1007/s12032-024-02532-0.
9
Prevalence of the cancer-associated germline variants in Russian adults and long-living individuals: using the ACMG recommendations and computational interpreters for pathogenicity assessment.俄罗斯成年人和长寿个体中癌症相关种系变异的患病率:采用美国医学遗传学与基因组学学会(ACMG)的建议及致病性评估的计算解释工具
Front Oncol. 2024 Sep 5;14:1420176. doi: 10.3389/fonc.2024.1420176. eCollection 2024.
10
A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology.生物信息学工具在基因组生物标志物发现中的应用综述——推动精准肿瘤学发展
Genes (Basel). 2024 Aug 6;15(8):1036. doi: 10.3390/genes15081036.